Elevated receptor tyrosine kinases, such as epidermal growing factor receptor (EGFR), fibroblast growth factor 2 (FGF2), c-Kit, platelet-derived growth factor (PDGF), and its receptor (PDGFR), have been shown to affect the prognosis of gastric cancer patients. The gene discussed is FGF2; the disease is gastric cancer.